Non Alcoholic Fatty Liver Disease - Epidemiology Forecast to 2027

Non Alcoholic Fatty Liver Disease - Epidemiology Forecast to 2027

Category

Pharmaceuticals

Published Date

1st Feb 2018

Pages

50

Choose License

Final Price

DelveInsight's "Non Alcoholic Fatty Liver Disease (NAFLD) - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Non Alcoholic Fatty Liver Disease (NAFLD) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2027

Non Alcoholic Fatty Liver Disease (NAFLD) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Non Alcoholic Fatty Liver Disease (NAFLD) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Non Alcoholic Fatty Liver Disease (NAFLD) outlook. It also includes the explanation of changing trends of epidemiology outlining the Non Alcoholic Fatty Liver Disease (NAFLD) scenario.

Non Alcoholic Fatty Liver Disease (NAFLD) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Non Alcoholic Fatty Liver Disease (NAFLD) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Non Alcoholic Fatty Liver Disease (NAFLD) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Non Alcoholic Fatty Liver Disease (NAFLD) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Non Alcoholic Fatty Liver Disease (NAFLD)

Key assessments
• Patient Segmentation in Non Alcoholic Fatty Liver Disease (NAFLD)
• Non Alcoholic Fatty Liver Disease (NAFLD) Risk & Burden
• Factors driving growth in a specific Non Alcoholic Fatty Liver Disease (NAFLD) patient population
1. Report Introduction
2. Non Alcoholic Fatty Liver Disease (NAFLD) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Non Alcoholic Fatty Liver Disease (NAFLD) in 2017
2.2. Patient Share Distribution of Non Alcoholic Fatty Liver Disease (NAFLD) in 2027
3. Disease Background and Overview: Non Alcoholic Fatty Liver Disease (NAFLD)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Non Alcoholic Fatty Liver Disease (NAFLD) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Non Alcoholic Fatty Liver Disease (NAFLD) in 7MM – By Countries
5. Epidemiology of Non Alcoholic Fatty Liver Disease (NAFLD) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Non Alcoholic Fatty Liver Disease (NAFLD)
5.1.3. Sub-Type Specific cases of the Non Alcoholic Fatty Liver Disease (NAFLD) *
5.1.4. Sex- Specific Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) *
5.1.5. Diagnosed Cases of the Non Alcoholic Fatty Liver Disease (NAFLD)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Non Alcoholic Fatty Liver Disease (NAFLD)
5.4.3. Sub-Type Specific cases of the Non Alcoholic Fatty Liver Disease (NAFLD) *
5.4.4. Sex- Specific Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) *
5.4.5. Diagnosed Cases of the Non Alcoholic Fatty Liver Disease (NAFLD)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Non Alcoholic Fatty Liver Disease (NAFLD)
5.5.3. Sub-Type Specific cases of the Non Alcoholic Fatty Liver Disease (NAFLD) *
5.5.4. Sex- Specific Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) *
5.5.5. Diagnosed Cases of the Non Alcoholic Fatty Liver Disease (NAFLD)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Non Alcoholic Fatty Liver Disease (NAFLD)
5.6.3. Sub-Type Specific cases of the Non Alcoholic Fatty Liver Disease (NAFLD) *
5.6.4. Sex- Specific Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) *
5.6.5. Diagnosed Cases of the Non Alcoholic Fatty Liver Disease (NAFLD)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Non Alcoholic Fatty Liver Disease (NAFLD)
5.7.3. Sub-Type Specific cases of the Non Alcoholic Fatty Liver Disease (NAFLD) *
5.7.4. Sex- Specific Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) *
5.7.5. Diagnosed Cases of the Non Alcoholic Fatty Liver Disease (NAFLD)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Non Alcoholic Fatty Liver Disease (NAFLD)
5.8.3. Sub-Type Specific cases of the Non Alcoholic Fatty Liver Disease (NAFLD) *
5.8.4. Sex- Specific Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) *
5.8.5. Diagnosed Cases of the Non Alcoholic Fatty Liver Disease (NAFLD)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Non Alcoholic Fatty Liver Disease (NAFLD)
5.9.3. Sub-Type Specific cases of the Non Alcoholic Fatty Liver Disease (NAFLD) *
5.9.4. Sex- Specific Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) *
5.9.5. Diagnosed Cases of the Non Alcoholic Fatty Liver Disease (NAFLD)
6. Unmet Needs of the Non Alcoholic Fatty Liver Disease (NAFLD)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific
Table 1: Total Prevalent/Incident Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in 7MM
Table 2: Total Prevalent/Incident Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in United States (2016-2027)
Table 4: Sub-Type Specific cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in United States (2016-2027)*
Table 5: Sex- Specific Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in United States (2016-2027)*
Table 6: Diagnosed Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in United States (2016-2027)
Table 7: Prevalent/Incident Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in Germany (2016-2027)
Table 8: Sub-Type Specific cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in Germany (2016-2027) *
Table 9: Sex- Specific Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in Germany (2016-2027) *
Table 10: Diagnosed Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in Germany (2016-2027)
Table 11: Prevalent/Incident Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in France (2016-2027)
Table 12: Sub-Type Specific cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in France (2016-2027) *
Table 13: Sex- Specific Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in France (2016-2027) *
Table 14: Diagnosed Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in France (2016-2027)
Table 15: Prevalent/Incident Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in Italy (2016-2027)
Table 16: Sub-Type Specific cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in Italy (2016-2027) *
Table 17: Sex- Specific Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in Italy (2016-2027) *
Table 18: Diagnosed Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in Italy (2016-2027)
Table 19: Prevalent/Incident Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in Spain (2016-2027)
Table 20: Sub-Type Specific cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in Spain (2016-2027) *
Table 21: Sex- Specific Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in Spain (2016-2027) *
Table 22: Diagnosed Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in Spain (2016-2027)
Table 23: Prevalent/Incident Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in UK (2016-2027)
Table 24: Sub-Type Specific cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in UK (2016-2027) *
Table 25: Sex- Specific Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in UK (2016-2027) *
Table 26: Diagnosed Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in UK (2016-2027)
Table 27: Prevalent/Incident Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in Japan (2016-2027)
Table 28: Sub-Type Specific cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in Japan (2016-2027) *
Table 29: Sex- Specific Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in Japan (2016-2027) *
Table 30: Diagnosed Cases of the Non Alcoholic Fatty Liver Disease (NAFLD) in Japan (2016-2027)

Get Free Sample

You can get a FREE sample of any report. Just click the "Free Sample" link.

Explore Latest Reports

If you have any special requirement or looking for more discounts, Kindly contact our sales team

Contact Us